COVID-19 Notification of Contract Award
AB Scientific’s bid for Lot 2 of the HealthTrust Europe COVID-19 Testing Framework Agreement has been successful!
Further to the notification of our award letter, in which AB Scientific was advised that HealthTrust Europe was observing a standstill under the Public Contracts Regulations 2015, HealthTrust Europe (“HTE”) formally accepted our contractual offer for Lot 2 – COVID-19 Laboratory-Based Testing of the new Framework Agreement.
HealthTrust Europe sought to establish a framework agreement for the supply of COVID-19 Testing equipment, consumables and related services. The framework was structured into two lots. The first lot would provide a comprehensive range of COVID-19 point of care testing rapid diagnostic testing products to include handheld devices, bench-top devices, connected and non-connected devices, as well as consumables, such as test strips and cassettes, and other products that can be properly described as point of care or near-patient testing for COVID-19. The second lot, which AB Scientific has been awarded, will provide a comprehensive range of laboratory testing equipment, reagents, associated consumables and services for lab testing of COVID-19.
All equipment and/or in-vitro diagnostic systems offered by AB Scientific (including the ePlex system from GenMark), and reagents and consumables fully comply with the relevant European medical, electrical, mechanical standards and directives, including:
- Being CE marked, where required
- Conforming with the IVD Directive 98/79/EC and any other relevant European Directives
- Packaging complying with the relevant European Directives
- ISO 22870:2016 compliance for quality and competence
- ISO 15189:2012 compliance for laboratory diagnostics
AB Scientific is honoured to work with HTE on their continued effort in supporting the UK healthcare system in battling COVID-19
Press Contact: Christopher Rawlinson, Group Sales Manager
Phone: +44 (0)7882 505 647